MedTrace Logo

Motor Cortex Stimulation for Chronic Neuropathic Pain

NCT01554332 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2020-06-12

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy of cortical stimulation (CS) as an adjunctive treatment for chronic neuropathic pain.

Conditions

  • Neuropathic Pain
  • Facial Pain
  • Post-stroke Pain
  • Brachial Plexus Avulsion
  • Phantom Limb Pain of the Upper Extremities

Interventions

DEVICE

Motor Cortex Stimulation using SJM EonC Stimulator

Patients will be randomized to receive either active stimulation the first 3 months followed by a one-month washout, followed by Sham Stimulation the next 3 months, vs. the reverse order of treatment, followed by single blind stimulation, and an open label phase.

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Edward Karst · Abbott Neuromodulation

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01554332 on ClinicalTrials.gov